Biotech / MedTech

Singapore-based healthcare-dedicated asset management firm CBC Group announced that its controlled portfolio company, Hasten Biopharmaceutical (Hasten), an innovation-driven biopharmaceutical company, has successfully acquired the asset rights of 14 branded products across Pan-Asia countries and regions from Celltrion, a South Korean biopharmaceutical…

HSBC has levelled up its strategic partnership with Gene Solutions, a biotechnology company based in Vietnam, through a social loan which allows the firm to continue expanding its healthcare services to Vietnam and ASEAN’s citizens.

Singapore state-owned investor Temasek has led EUR 188 million ($208 million) equity investment in German radiopharmaceutical biotech firm ITM Isotope Technologies Munich SE (ITM).

Allozymes, a Singapore-based innovator in enzyme discovery and engineering, has on Monday announced the closing of a $15 million Series A funding round led by Seventure Partners of France and Xora Innovation of Singapore.

NSG BioLabs, Singapore's largest provider of biotech co-working laboratory and office space, has successfully concluded a $14.5 million financing round. The round was led by Celadon Partners, an Asian private equity firm.

As we peer into the future of the APAC biotech landscape, biotech startups will continue to see opportunities for innovation and funding on the horizon. The anticipated trends in strategic investments, government support, and collaborative efforts suggest that 2024 will be a pivotal year for aspiring biotech entrepreneurs. Success in this dynamic landscape…

South Korea’s private sector-led shared research lab S&S Lab (the operator of IRIS Lab) has announced its latest strategic partnership with Singapore innovation ecosystem enabler Farquhar VC (FVC), to foster and deepen relations among Korean and global novel food and biotech startups.

Moosa Genetics, an animal genomics and biotechnology startup based in Indonesia, has on Monday announced that the company raised funding led by East Ventures, a venture capital firm focusing on Southeast Asia. The funding also saw the participation from angel investors.

Automera, a new biotechnology company based in Singapore, has secured $16 million in Series A funding co-led by Accelerator Life Science Partners (ALSP) and ClavystBio. The funding also saw participation from Singapore-based global investor EDBI, Xora Innovation, and other undisclosed investors.

The July InnovaTalk Webinar hosted by the VinFuture Foundation highlighted the most recent research endeavors in understanding the interaction between medication drugs and the human gut microbiome, their implications on various complications including Antimicrobial Resistance and malnutrition, and challenges and opportunities to expand microbiome research…